Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo-Cheng Huang

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Physical Chemistry Chemical Physics : PCCP|September 20, 2022
Structural insights into Nirmatrelvir (PF-07321332)-3C-like SARS-CoV-2 protease complexation: a ligand Gaussian accelerated molecular dynamics studyYeng-Tseng Wang, Jun-Min Liao, Wen-Wei Lin, et al.
International Journal of Biological Macromolecules|March 17, 2024
Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumabYi-Jung Huang, Kai-Wen Ho, Tian-Lu Cheng, et al.
Chemical Science|August 5, 2021
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodiesBo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao, et al.
Chemical Science|August 11, 2021
Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodiesBo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao, et al.
Scientific Reports|July 11, 2019
Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane proteinChien-Chiao Huang, Kai-Wen Cheng, Yuan-Chin Hsieh, et al.
Journal of Translational Medicine|May 22, 2026
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissueYu-Tung Chen, Zih-Yu Jhuang, Pin-Jie Li, et al.
Scientific Reports|April 8, 2021
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapyWen-Wei Lin, Yi-An Cheng, Chia-Ching Li, et al.
International Journal of Biological Macromolecules|January 22, 2025
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancerKai-Wen Ho, Yen-Ling Liu, Bo-Cheng Huang, et al.
Biomaterials Research|December 12, 2024
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In VivoYen-Ling Liu, Tzu-Yi Liao, Kai-Wen Ho, et al.
Journal of Nanobiotechnology|January 10, 2021
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activityKai-Wen Ho, I-J U Chen, Yi-An Cheng, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Physical Chemistry Chemical Physics : PCCP|September 20, 2022
Structural insights into Nirmatrelvir (PF-07321332)-3C-like SARS-CoV-2 protease complexation: a ligand Gaussian accelerated molecular dynamics studyYeng-Tseng Wang, Jun-Min Liao, Wen-Wei Lin, et al.
International Journal of Biological Macromolecules|March 17, 2024
Selective activation of IFNγ-ipilimumab enhances the therapeutic effect and safety of ipilimumabYi-Jung Huang, Kai-Wen Ho, Tian-Lu Cheng, et al.
Chemical Science|August 5, 2021
Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodiesBo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao, et al.
Chemical Science|August 11, 2021
Correction: Development of a structure-based computational simulation to optimize the blocking efficacy of pro-antibodiesBo-Cheng Huang, Yun-Chi Lu, Jun-Min Liao, et al.
Scientific Reports|July 11, 2019
Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane proteinChien-Chiao Huang, Kai-Wen Cheng, Yuan-Chin Hsieh, et al.
Journal of Translational Medicine|May 22, 2026
Tumor-associated protease-activated anti-CD47 antibody precisely maintains phagocytic ability of macrophages with minimal effect on healthy tissueYu-Tung Chen, Zih-Yu Jhuang, Pin-Jie Li, et al.
Scientific Reports|April 8, 2021
Enhancement of tumor tropism of mPEGylated nanoparticles by anti-mPEG bispecific antibody for ovarian cancer therapyWen-Wei Lin, Yi-An Cheng, Chia-Ching Li, et al.
International Journal of Biological Macromolecules|January 22, 2025
Targeted internalization and activation of glycosidic switch liposomes by a biological macromolecule mPEG×EphA2 increases therapeutic efficacy against lung cancerKai-Wen Ho, Yen-Ling Liu, Bo-Cheng Huang, et al.
Biomaterials Research|December 12, 2024
Impact of Pre-existing Anti-polyethylene Glycol Antibodies on the Pharmacokinetics and Efficacy of a COVID-19 mRNA Vaccine (Comirnaty) In VivoYen-Ling Liu, Tzu-Yi Liao, Kai-Wen Ho, et al.
Journal of Nanobiotechnology|January 10, 2021
Double attack strategy for leukemia using a pre-targeting bispecific antibody (CD20 Ab-mPEG scFv) and actively attracting PEGylated liposomal doxorubicin to enhance anti-tumor activityKai-Wen Ho, I-J U Chen, Yi-An Cheng, et al.
Pageof 3